Founded in 2012, RusnanoMedInvest is a venture capital firm created to effect the partnership between the Russian RUSNANO State Corporation and Domain Associates, L.L.C. signed in March 2012. RMI is headquartered in Moscow, Russia.

Life sciences Venture Fund RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100-percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co-investment in nanotechnology projects with substantial economic potential or social benefit. RMI’s key objectives are to advance projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia.

www.rmi.com.ru/en